Friday, Apr 20 2018 | Time 20:21 Hrs(IST)
image
image image
  • 80 lakh remaining families to be covered in Bihar under Extended PM Ujjawala Yojana
  • Clash betwen two communities in Phagwara
  • Punjab releases 60,000 gas connections on Ujjwala Diwas
  • Haryana to form Durga Vahini squads to stop women from being harassed in public spaces : CM
  • Sunanda Pushkar case: Delhi Police files affidavit, updates current status to SC
  • Kangra valley drenched as mercury dips
  • JSW Bengaluru FC best team in this season at Indian domestic level: Roca
  • APCC shows demonstration in front of SBI
  • Khattar directs DCs to get survey conducted to ensure every household has gas cylinder
  • Mehbooba express grief over death of Sachar
  • Centre extends ceasefire with NSCN-NK & NSCN-R till 2019
  • JSW Bengaluru FC beat Kingfisher East Bengal 4-1 in inaugural Hero Super Cup final
  • Warm, dusty day in Delhi, air quality poor
  • Protest by some people cannot take away excellent Q&A session, Omar
  • Cash of Rs 32 54 crore seized for Code of Conduct violations in Karnataka
Science Technology Share

MedGenome launches liquid biopsy blood test 'Oncotrack' for cancer detection in patients

MedGenome launches liquid biopsy blood test 'Oncotrack' for  cancer detection in patients

Mumbai, Mar 8 (UNI) MedGenome, the country's premier Genomics-based research and diagnostics company, has launched 'Oncotrack', the liquid biopsy blood test, for cancer recurrence detection and monitoring. The Oncotrack is a non-invasive screening test that is set to transform the way physicians in India can identify genetic alterations, interpret, assess and treat various forms of cancers. Launching the blood test yesterday, Chief operation officer of MedGenome, Dr V L Ramprasad said, 'Liquid biopsy has the capacity to interpret infinite mutations which will pave the way for new drug discovery, research and therapies. Over 35 oncologists in India have already screened patients using our Oncotrack. Further, since it has a very patient-friendly approach, we are confident it will be very well accepted by both the doctors and patients.' India is likely to have over 1.73 million new cases of cancer and over 8,80,000 deaths due to the disease by 2020. Around 70 per cent of all cancer patients approach the doctor when the disease has advanced, and the chances of cure are very low. 'Management of cancer will undergo a massive transformation in India with NGS-based liquid biopsies. We are constantly striving to get the most advanced genetic testing technology/ technique at affordable prices to the patients and Oncotrack is one such offering,' said Sam Santhosh, chairman, MedGenome. The test, developed entirely by MedGenome, is the only one to be validated in India and verified from samples of cancer patients from across the country. The test screens the samples by analyzing cell-free DNA that is isolated from the patients’ blood. Using high-end sequencing technology, the screening process identifies specific gene mutations that are linked with Melanoma, Lung and Colon cancers. The test facilitates detection of mutation where there is difficulty of obtaining biopsy or in the event of a damaged biopsy material and non-availability of tissue biopsy. This offers oncologists the power to look for actionable alterations in a patient's treatment, management, without having to do an invasive biopsy or where biopsy is not an option. Oncotrack is a proven molecular tool after histopathology diagnosis and detecting molecular changes at baseline and at the time of relapse in lung and colon cancer for deciding the right treatment. The test has been validated in a scientific study, in academic collaboration with Tata Memorial Hospital -- Dr Kumar Prabhash, medical oncologist, and Dr Amit Dutt, principal investigator (Scientist F) at ACTREC, Tata Memorial Centre. UNI ST SS RSA SB 1043

More News
Evidence shows banning asbestos has no negative economic impact

Evidence shows banning asbestos has no negative economic impact

20 Apr 2018 | 11:56 AM

Kolkata, Apr 20 (UNI) Sound scientific evidence shows that any exposure to asbestos fibres poses significant health risks.

 Sharesee more..
Nadda directs for comprehensive strategy to tackle leprosy, TB

Nadda directs for comprehensive strategy to tackle leprosy, TB

17 Apr 2018 | 6:47 PM

New Delhi, Apr 17 (UNI) Union Minister for Health and Family Welfare JP Nadda directed for a comprehensive strategy for addressing incidence, prevalence and surveillance aspects to eliminate leprosy at district level and reviewed Tuberculosis Control Programme on Tuesday.

 Sharesee more..
Fortis Hospital performs Double Root Translocation surgery to cure 3-year-old Kashmiri boy

Fortis Hospital performs Double Root Translocation surgery to cure 3-year-old Kashmiri boy

14 Apr 2018 | 4:32 PM

New Delhi, Apr 14 (UNI A team of doctors at Fortis Memorial Research Institute (FMRI) recently performed a rare Double Root Translocation Surgery to cure three-year Mohammed Aasim, from Safapora, Ganderbal in Jammu and Kashmir recently.

 Sharesee more..
WHO and UNICEF issue new guidance to promote breastfeeding in health facilities globally

WHO and UNICEF issue new guidance to promote breastfeeding in health facilities globally

12 Apr 2018 | 2:25 PM

Kolkata, Apr 12 (UNI) WHO and UNICEF on Wednesday issued new ten-step guidance to
increase support for breastfeeding in health facilities that provide maternity and newborn
services.

 Sharesee more..

Northern Syria: access to primary health care gives hope to malnourished child

11 Apr 2018 | 12:52 PM

Damascus , Apr 11 (UNI) Sham was 6 months old when her worried mother, Ghadir, brought her to a health facility in the town of Al-Zafaranah, about 30 kilometres from her village in the embattled countryside
north of Homs, Syria.

 Sharesee more..
image